Cancer Research Technology
Log in Register
Menu

Anti-CD45R [YTH 80.103]

Invented by Herman Waldmann
Invented at University of Cambridge

Info

Applications FACS IHC
Antigen/Gene or Protein Targets Human CD45R
Synonyms Protein Tyrosine Phosphatase; Receptor Type C; CD45 Antigen; CD45; L-CA; T200; Protein Tyrosine Phosphatase; Receptor Type; C Polypeptide; T200 Leukocyte Common Antigen; T200 Glycoprotein; EC 3.1.3.48; GP180; CD45R; B220; LCA; LY5
Reactivity Human
Relevance CD45R, also known as B220, is an isoform of CD45. It is a member of the protein tyrosine phosphatase (PTP) family with a molecular weight of approximately 180-240 kD. CD45R is expressed on B cells (at all developmental stages from pro-B cells through mature B cells), activated B cells, and subsets of T and NK cells. CD45R (B220) is also expressed on a subset of abnormal T cells involved in the pathogenesis of systemic autoimmunity in MRL-Faslpr and MRL-Fasgld mice. It plays a critical role in TCR and BCR signaling. The primary ligands for CD45 are galectin-1, CD2, CD3, and CD4. CD45R is commonly used as a pan-B cell marker; however, CD19 may be more appropriate for B cell specificity.
Host Mouse
Subclass IgG2b
Research Area Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction, Immunology, Stem Cell Biology

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Hale et al. 1985. J Immunol. 134(5):3056-61. PMID: 3980990.


Add a reference

References: 1 entry

Hale et al. 1985. J Immunol. 134(5):3056-61. PMID: 3980990.


Add a reference

Inventor Information